Clinical trial · Interventional
Frailty Syndrome of Post-cancer Treatment Eldery Patients
Impact of Exercise and Nutritional Support on the Frailty Syndrome of Eldery Patients in Phase of Post-cancer Treatment
NCT04746768CI-TRIAL-00052155PANACEEunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Decrease the prevalence of frailty syndrome in individuals with complete response of cancer.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Exercise | — | UNRESOLVED | — |
| Frailty Syndrome | — | UNRESOLVED | — |
| Nutritional Support | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| exercise and nutritional support | Combination Product | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- exercise and nutritional support
- description
- exercise and nutritional support program during an active support phase (0 to 6 months) followed by an empowerment phase (from 6 to 12 months)
- interventionNames
- Combination Product: exercise and nutritional support
Primary outcomes (1)
- measure
- Change of the prevalence of frailty syndrome in individuals with complete response of cancer
- timeFrame
- 0, 6 and 12 months
- description
- evolution of individual frailty during a multimodal intervention (physical and nutritional activity) according to the Fried's criteria
Secondary outcomes (8)
- measure
- evaluation of predicitive variables of frailty syndrome reversion
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * in complete remission from cancer (all type of cancer) * have a frailty syndrome (positive GFST score) * ability to provide signed informed consent * be affiliated with social security or beneficiary of such a scheme Exclusion Criteria: * patient with active cancer or any other pathology affecting the prognosis at 5 years * currently participating or having participated in the month preceding inclusion in another interventional clinical research that may impact the study. This impact is left to the investigator discretion * subjects referred to articles L1121-5 to L1121-8 of CSP (corresponds to all protected persons: person deprived of liberty by judicial or administrative decision, person subject to legal protection measure)
References
Publications (1)
- DERIVEDDrevet S, Agbogbo MA, Ghaith A, Chardon M, Guinot M, Coudurier M, Doutreleau S, Lumale S, Musso N, Petit P, Lopez C, Penkov G, El Mouzdahir E, Mouret S, Liuu E, Vuillerme N, Flore P, Gavazzi G. Improvement of frailty and prefrailty in older cancer survivors: a 6-month home-based pilot study. Age Ageing. 2026 Aug 3;55(8):afag245. doi: 10.1093/ageing/afag245. PMID 42621847